# Thermo Fisher Scientific Inc. (TMO) stock price

URL: https://funkfolio.com/stock/TMO

> Thermo Fisher Scientific Inc. (TMO) trades at $686.79, is worth $254.47B, is priced at 36.2× earnings and scores 37/100.

---

## Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Scientific Inc. (TMO) is a healthcare company (diagnostics & research) based in the United States. The share price is $686.79, down 0.66% on the day, which values the company at $254.47B. Price as of 17 Nov 2026, 22:33 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $686.79 −0.66% today
- **Market value:** $254.47B
- **P/E ratio:** 36.2× last 12 months
- **Forward P/E:** 24.7×
- **Dividend yield:** 0.27%
- **Funk Score:** 37/100
- **Against its own history:** Well above its usual price usual price $389.51
- **200-week average:** $538.82 27% above

Figures as of 17 Nov 2026, 22:33 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Thermo Fisher Scientific Inc. in more detail

TMO trades at 36.2× its last twelve months' earnings, 24.7× next year's expected earnings, 5.4× sales. Measured against its own history, the price is 76% above what its usual multiples would imply ($389.51) — well above its usual price. It sits 27% above its 200-week average of $538.82.

Over the last five fiscal years Thermo Fisher Scientific Inc. has compounded revenue 6.7% a year, earnings per share 2.1% a year, free cash flow -1.6% a year. Its Funk Score is 37 out of 100 (financial strength 4.6, profitability 5.1, growth 3.2, value 1.9, each out of 10).

In its favour: Altman Z in the safe zone; Share count keeps falling. Worth checking: Debt is growing faster than cash flow.

24 of the superinvestors tracked here hold TMO, including Nick Train (12.4% of the portfolio), Larry Robbins (6.3% of the portfolio), Wallace Weitz (4.9% of the portfolio).

### Superinvestors holding TMO

24 of the investors tracked here report a position in their latest 13F filing.

- [Nick Train Lindsell Train](https://funkfolio.com/gurus/nick-train) 12.4% of portfolio · $293.1M · trimmed · Q3 2026
- [Larry Robbins Glenview Capital Management](https://funkfolio.com/gurus/larry-robbins) 6.28% of portfolio · $314.5M · added · Q2 2026
- [Wallace Weitz Weitz Investment Management](https://funkfolio.com/gurus/wallace-weitz) 4.85% of portfolio · $70.9M · trimmed · Q3 2026
- [Jeremy Grantham (co-founder) GMO (Grantham, Mayo, Van Otterloo)](https://funkfolio.com/gurus/jeremy-grantham) 4.30% of portfolio · $2B · added · Q3 2026
- [Andreas Halvorsen Viking Global Investors](https://funkfolio.com/gurus/andreas-halvorsen) 2.77% of portfolio · $971.3M · added · Q2 2026
- [Harry Burn Sound Shore Management](https://funkfolio.com/gurus/harry-burn) 2.69% of portfolio · $86M · trimmed · Q3 2026
- [Temasek Temasek Holdings](https://funkfolio.com/gurus/temasek) 2.24% of portfolio · $814.3M · added · Q3 2026
- [Doug Silverman Senator Investment Group](https://funkfolio.com/gurus/doug-silverman) 2.04% of portfolio · $53.9M · trimmed · Q3 2026
- [Steven Romick First Pacific Advisors (FPA)](https://funkfolio.com/gurus/steven-romick) 1.98% of portfolio · $165.7M · trimmed · Q3 2026
- [Diamond Hill team Diamond Hill Capital Management](https://funkfolio.com/gurus/diamond-hill) 1.62% of portfolio · $148.4M · trimmed · Q3 2026
- [Andrew Spokes Farallon Capital Management](https://funkfolio.com/gurus/farallon) 1.57% of portfolio · $300.9M · trimmed · Q3 2026
- [John Armitage Egerton Capital](https://funkfolio.com/gurus/john-armitage) 1.36% of portfolio · $133.8M · new · Q3 2026
- [Dodge & Cox team Dodge & Cox](https://funkfolio.com/gurus/dodge-and-cox) 1.10% of portfolio · $2B · trimmed · Q3 2026
- [Primecap team Primecap Management](https://funkfolio.com/gurus/primecap) 0.79% of portfolio · $1.3B · trimmed · Q3 2026
- [Daniel Sundheim D1 Capital Partners](https://funkfolio.com/gurus/daniel-sundheim) 0.73% of portfolio · $233.6M · trimmed · Q3 2026
- [Ken Fisher Fisher Investments](https://funkfolio.com/gurus/ken-fisher) 0.58% of portfolio · $2B · added · Q3 2026
- [Tom Gayner Markel Group](https://funkfolio.com/gurus/tom-gayner) 0.39% of portfolio · $50M · added · Q3 2026
- [Baillie Gifford team Baillie Gifford & Co](https://funkfolio.com/gurus/baillie-gifford) 0.39% of portfolio · $408.5M · trimmed · Q3 2026
- [Stanley Druckenmiller Duquesne Family Office](https://funkfolio.com/gurus/stanley-druckenmiller) 0.22% of portfolio · $9.6M · new · Q2 2026
- [Steve Cohen Point72 Asset Management](https://funkfolio.com/gurus/steve-cohen) 0.21% of portfolio · $139.2M · trimmed · Q2 2026
- [David Shaw (founder) D. E. Shaw & Co.](https://funkfolio.com/gurus/david-shaw) 0.20% of portfolio · $321.7M · added · Q2 2026
- [Ken Griffin Citadel Advisors](https://funkfolio.com/gurus/ken-griffin) 0.17% of portfolio · $288.3M · trimmed · Q2 2026
- [Joel Greenblatt Gotham Asset Management](https://funkfolio.com/gurus/joel-greenblatt) 0.16% of portfolio · $69.9M · added · Q2 2026
- [Paul Tudor Jones Tudor Investment Corp](https://funkfolio.com/gurus/paul-tudor-jones) 0.15% of portfolio · $35.7M · added · Q2 2026

### Health Care companies of similar size

- [Eli Lilly LLY](https://funkfolio.com/stock/LLY)
- [Johnson & Johnson JNJ](https://funkfolio.com/stock/JNJ)
- [AbbVie ABBV](https://funkfolio.com/stock/ABBV)
- [Merck & Co MRK](https://funkfolio.com/stock/MRK)
- [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH)
- [Novartis NVS](https://funkfolio.com/stock/NVS)
- [AstraZeneca AZN](https://funkfolio.com/stock/AZN)
- [Amgen AMGN](https://funkfolio.com/stock/AMGN)
- [Gilead Sciences GILD](https://funkfolio.com/stock/GILD)
- [Abbott Laboratories ABT](https://funkfolio.com/stock/ABT)
- [Novo Nordisk NVO](https://funkfolio.com/stock/NVO)
- [Pfizer PFE](https://funkfolio.com/stock/PFE)

Side by side: [TMO vs AMGN (Thermo Fisher Scientific Inc. vs Amgen)](https://funkfolio.com/compare/amgn-vs-tmo) [TMO vs AZN (Thermo Fisher Scientific Inc. vs AstraZeneca)](https://funkfolio.com/compare/azn-vs-tmo) [TMO vs NVS (Thermo Fisher Scientific Inc. vs Novartis)](https://funkfolio.com/compare/nvs-vs-tmo) [TMO vs GILD (Thermo Fisher Scientific Inc. vs Gilead Sciences)](https://funkfolio.com/compare/gild-vs-tmo) [TMO vs UNH (Thermo Fisher Scientific Inc. vs UnitedHealth Group)](https://funkfolio.com/compare/tmo-vs-unh)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Thermo Fisher Scientific Inc. (TMO): questions and answers

**What is TMO's P/E ratio?**

Thermo Fisher Scientific Inc. trades at 36.2× its last twelve months' earnings and 24.7× next year's expected earnings. At its fiscal year-ends over the past 19 years the P/E ranged from 13.0× to 35.4×, with a median of 30.9×.

**What is TMO's PEG ratio?**

Thermo Fisher Scientific Inc.'s PEG ratio is 2.00 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is Thermo Fisher Scientific Inc.'s market cap?**

Thermo Fisher Scientific Inc. is valued at $254.47B at a share price of $686.79.

**Is TMO overvalued or undervalued?**

Against its own history, TMO is well above its usual price: the price is 76% above the $389.51 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is TMO above its 200-week moving average?**

Yes. TMO is 27.5% above its 200-week average of $538.82. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Thermo Fisher Scientific Inc. growing?**

Over the last five fiscal years Thermo Fisher Scientific Inc.'s revenue grew 6.7% a year and its earnings per share 2.1% a year; over ten years revenue grew 10.1% a year.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Thermo Fisher Scientific Inc. (TMO) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/TMO

Underlying data: Yahoo Finance; company filings with the SEC.
